BioCardia, Inc.
News
(2)April 2026
BCDA achieves PMDA alignment for US data supporting Japanese market clearance
# 🧾 What This Document Is 📰 This filing is a Form 8-K, which is a report used to announce major, unscheduled corporate events that shareholders and the public should know about right away. Instead of detailing routine financial updates, this document is primarily a press release outlining a major
BioCardia, Inc. — 8-K Filing
# 🧾 What This Document Is This is an **8-K filing**, which is a current report companies use to announce major events to shareholders. Think of it as a breaking news alert to the market. BioCardia is telling investors it has formally asked the FDA for a meeting to discuss a faster path to getting i
Peers in Biotechnology
Vertex Pharmaceuticals Incorporated
Regeneron Pharmaceuticals, Inc.
argenx SE
Alnylam Pharmaceuticals, Inc.
BeOne Medicines AG
Insmed Incorporated
Royalty Pharma plc
BioNTech SE
Roivant Sciences Ltd.
Moderna, Inc.